Luis-Antonio Corchete

28PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsDisease surveillanceMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 17, 2026
Study of post-translational modifications of p53 in multiple myeloma.

|Jun 03, 2026
MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

|Jun 02, 2025
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.

Alena Sophie Ehrmann, Miguel Quijada-Álamo, Viola Close

|Mar 19, 2025
Regional patterns of early-onset colorectal cancer from the GEOCODE (Global Early-Onset COlorectal Cancer DatabasE)-European consortium: retrospective cohort study.

Maria Daca-Alvarez, José Perea, Luis Corchete

|May 24, 2024
Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome.

Patricia Alejandra Garrido Ruiz, Álvaro Otero Rodriguez, Luis Antonio Corchete

|May 11, 2024
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.

Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad

Pageof 5

Frequent Collaborators

4 joint publications

Rosario Vidal-Tocino

4 joint publications

José Perea

4 joint publications

José María Sayagués

3 joint publications

Rogelio González-Sarmiento